This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2012 Feb 25;379(9817):689-90.

doi: 10.1016/S0140-6736(12)60118-4. Epub 2012 Jan 24.

Human embryonic stem cells: early hints on safety and efficacy

Anthony Atala¹

Affiliations

PMID: 22281387
DOI: 10.1016/S0140-6736(12)60118-4

Comment

Human embryonic stem cells: early hints on safety and efficacy

Anthony Atala. Lancet. 2012.

. 2012 Feb 25;379(9817):689-90.

doi: 10.1016/S0140-6736(12)60118-4. Epub 2012 Jan 24.

Author

Anthony Atala¹

Affiliation

¹ Wake Forest Institute for Regenerative Medicine, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA. aatala@wakehealth.edu

PMID: 22281387
DOI: 10.1016/S0140-6736(12)60118-4

No abstract available

PubMed Disclaimer

Comment on

Embryonic stem cell trials for macular degeneration: a preliminary report.
Schwartz SD, Hubschman JP, Heilwell G, Franco-Cardenas V, Pan CK, Ostrick RM, Mickunas E, Gay R, Klimanskaya I, Lanza R. Schwartz SD, et al. Lancet. 2012 Feb 25;379(9817):713-20. doi: 10.1016/S0140-6736(12)60028-2. Epub 2012 Jan 24. Lancet. 2012. PMID: 22281388

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information